TY - JOUR
KW - Adult
KW - buprenorphine
KW - Buprenorphine/therapeutic use
KW - capability index
KW - Consumption
KW - Crime/statistics & numerical data
KW - Criminality
KW - Female
KW - Great Britain
KW - Humans
KW - illicit drug use
KW - Maintenance Chemotherapy
KW - Male
KW - Medication Adherence/statistics & numerical data
KW - Methadone/therapeutic use
KW - Narcotics/therapeutic use
KW - opiate maintenance treatment
KW - Opiate Substitution Treatment/methods/psychology
KW - Opioid-Related Disorders/drug therapy/psychology
KW - Proportional Hazards Models
KW - Quality of Life
KW - Quality of Life/psychology
KW - randomized controlled trial
KW - supervised methadone
KW - Treatment Outcome
KW - treatment retention
AU - R. Holland
AU - V. Maskrey
AU - L. Swift
AU - C. Notley
AU - A. Robinson
AU - J. Nagar
AU - T. Gale
AU - C. Kouimtsidis
A1 - 
BT - Addiction (Abingdon, England)
C5 - Opioids & Substance Use
CP - 4
CY - England
DO - 10.1111/add.12439
IS - 4
JF - Addiction (Abingdon, England)
PB - Society for the Study of Addiction
PP - England
PY - 2014
SN - 1360-0443; 0965-2140
SP - 596
EP - 607
EP - 
T1 - Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial
T2 - Addiction (Abingdon, England)
TI - Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial
U1 - Opioids & Substance Use
U2 - 24304349
U3 - 10.1111/add.12439
VL - 109
VO - 1360-0443; 0965-2140
Y1 - 2014
ER -